Zydus Lifesciences share analysis
Zydus Lifesciences passes 4 of 5 fundamental tests, a score of 8/10. On the daily chart it is in a sideways range, RSI 45, 9% below its 52-week high: range-bound: no edge either way. Its own volatility puts the likely range at ₹1,049–₹1,202 a month from now and ₹887.24–₹1,421 in a year (68% bands).
Fundamentals 8/10
- Market cap
- ₹1,12,020 Cr
- P/E · forward
- 25.0 · 22.8
- PEG · P/B
- — · 4.2
- ROE · net margin
- — · +16%
- Revenue · earnings growth
- +22% · -36%
- Debt / equity
- 42%
- Dividend · beta
- 0.1% · 0.4
- Next results
- 5 Nov 2026
- ✓ Net margin above 10%
- ✓ Revenue growing over 10%
- ✕ Earnings growing
- ✓ Debt/equity under 100%
- ✓ Forward P/E under trailing (earnings expected up)
Swing technicals (daily)
- Trend
- sideways · 50d above 200d
- RSI(14)
- 45
- 20 / 50 / 200-day avg
- ₹1,155 / ₹1,145 / ₹1,022
- 20-day breakout
- above ₹1,232 · below ₹1,100
- ATR(14)
- ₹31.31 (2.8% a day)
- 52-week range
- ₹835.50 – ₹1,232
- Return 3m · 6m · 1y
- -2% · +20% · +13%
What the price could do
| In | Likely range (68%) |
|---|---|
| 1 mo | ₹1,049 – ₹1,202 (-7% / +7%) |
| 3 mo | ₹998.18 – ₹1,263 (-11% / +13%) |
| 6 mo | ₹950.64 – ₹1,327 (-15% / +18%) |
| 1 year | ₹887.24 – ₹1,421 (-21% / +27%) |
Analysts (29): hold, mean target ₹1,210 (+8%)
From its own volatility (24% a year), no drift assumed: what its swings allow, not a forecast.
Zydus Lifesciences news · last two days
News lean: Neutral- 17h agoZydus Presents Geographic Subgroup Analysis of Saroglitazar Trial in Primary Biliary CholangitisMachine Maker
- 23h agoFDA flags five observations at Zydus’ Moraiya plantpharma.economictimes.indiatimes
- 39h agoZydus Lifesciences share priceMint
- 3d agoZydus, Formycon move to front of Keytruda biosimilar raceBioWorld
- 3d agoZydus Lifesciences Enters Sri Lanka With USD 20 Million Manufacturing Unitwhalesbook
- 3d agoZydus Plans a USD 20 Million Drug Plant in Sri Lanka, With Output Expected in 2028Trade Brains
- 3d agoZydus Lifesciences Rises 2% on Sri Lanka Plant DealEquityPandit
- 3d agoZydus JV to Build Pharma Plant in Sri Lanka with $20M InvestmentRediff Money
- 3d agoZydus Sunshine Lifesciences signs agreement to set up pharma facility in Sri LankaExpress Pharma
- 4d agoStocks to Watch Today: Hero Motors, Tata Elxsi, SS Retail, Anand Rathi Share, Zydus Life, Hyundai Motor, Bharat Electronics, Bank of Baroda in focus on 14 OctoberMoneycontrol
Its order flow and footprint, the AI read of every headline, the expected move, and your own holdings beside it, with your broker connected.
Information and analytics for education only, not investment advice or a recommendation to buy or sell. Alephix Intelligence is not registered with SEBI as an investment adviser or research analyst. Prices may be delayed; figures come from public market data.